GSA Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$947K Buy
17,232
+2,421
+16% +$133K 0.07% 491
2025
Q1
$1.05M Buy
14,811
+7,393
+100% +$523K 0.09% 321
2024
Q4
$488K Buy
+7,418
New +$488K 0.04% 909
2024
Q2
Sell
-7,035
Closed -$614K 1637
2024
Q1
$614K Buy
+7,035
New +$614K 0.05% 761
2023
Q4
Sell
-6,373
Closed -$564K 1520
2023
Q3
$564K Sell
6,373
-638
-9% -$56.5K 0.05% 717
2023
Q2
$608K Buy
7,011
+4,376
+166% +$379K 0.06% 621
2023
Q1
$256K Sell
2,635
-1,908
-42% -$185K 0.03% 1122
2022
Q4
$470K Buy
+4,543
New +$470K 0.06% 641
2022
Q3
Sell
-19,438
Closed -$1.61M 1526
2022
Q2
$1.61M Sell
19,438
-2,352
-11% -$195K 0.24% 34
2022
Q1
$1.68M Buy
+21,790
New +$1.68M 0.23% 53
2021
Q4
Sell
-10,780
Closed -$833K 1421
2021
Q3
$833K Buy
10,780
+8,270
+329% +$639K 0.08% 399
2021
Q2
$209K Buy
+2,510
New +$209K 0.02% 1165
2018
Q4
Sell
-2,288
Closed -$222K 1364
2018
Q3
$222K Sell
2,288
-962
-30% -$93.3K 0.01% 1449
2018
Q2
$306K Sell
3,250
-491
-13% -$46.2K 0.02% 1379
2018
Q1
$303K Buy
+3,741
New +$303K 0.02% 1304
2017
Q2
Sell
-7,907
Closed -$694K 1679
2017
Q1
$694K Sell
7,907
-8,296
-51% -$728K 0.04% 884
2016
Q4
$1.34M Sell
16,203
-9,014
-36% -$747K 0.08% 386
2016
Q3
$2.33M Buy
25,217
+18,192
+259% +$1.68M 0.13% 186
2016
Q2
$547K Buy
+7,025
New +$547K 0.03% 1015
2016
Q1
Sell
-18,498
Closed -$1.94M 1676
2015
Q4
$1.94M Sell
18,498
-73,834
-80% -$7.74M 0.09% 271
2015
Q3
$9.72M Buy
92,332
+66,366
+256% +$6.99M 0.48% 11
2015
Q2
$3.55M Buy
25,966
+8,078
+45% +$1.11M 0.14% 117
2015
Q1
$2.23M Buy
+17,888
New +$2.23M 0.09% 287
2014
Q2
Sell
-37,363
Closed -$2.55M 1807
2014
Q1
$2.55M Buy
37,363
+29,754
+391% +$2.03M 0.18% 105
2013
Q4
$535K Buy
+7,609
New +$535K 0.04% 788
2013
Q3
Sell
-14,513
Closed -$809K 1561
2013
Q2
$809K Buy
+14,513
New +$809K 0.1% 292